Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Cascadian Therapeutics, Inc. | d640776dex322.htm |
| EX-32.1 - EX-32.1 - Cascadian Therapeutics, Inc. | d640776dex321.htm |
| EX-31.2 - EX-31.2 - Cascadian Therapeutics, Inc. | d640776dex312.htm |
| EX-31.1 - EX-31.1 - Cascadian Therapeutics, Inc. | d640776dex311.htm |
| EX-23.1 - EX-23.1 - Cascadian Therapeutics, Inc. | d640776dex231.htm |
| EX-10.18 - EX-10.18 - Cascadian Therapeutics, Inc. | d640776dex1018.htm |
| EX-10.16 - EX-10.16 - Cascadian Therapeutics, Inc. | d640776dex1016.htm |
| 10-K - 10-K - Cascadian Therapeutics, Inc. | d640776d10k.htm |
EXHIBIT 21.1
SUBSIDIARIES OF CASCADIAN THERAPEUTICS, INC.
| Name of Subsidiary | Jurisdiction of Incorporation | |
| Oncothyreon Canada ULC | Alberta | |
| Biomira Management, Inc. | Delaware | |
| ProlX Pharmaceuticals Corporation | Delaware | |
| 0811769 B.C. ULC | British Columbia | |
| Oncothyreon Luxembourg s.a.r.l. Protocell Therapeutics Inc. |
Luxembourg Delaware | |
| Cascadian Therapeutics (Australia) Pty Ltd | Australia |